A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)Stefano Cascinu, Giuseppina Catalano, Alessandro Morabito et al.|Annals of Oncology|1999Cited by 50